{
    "organizations": [],
    "uuid": "6cdd2bde91b3e1c48059d3ed47f1a30bc60645a0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-taiwan-advance-bio-pharmaceutical/brief-taiwan-advance-bio-pharmaceutical-receives-china-patent-idUSL4N1QB1SG",
    "ord_in_thread": 0,
    "title": "BRIEF-Taiwan Advance Bio-Pharmaceutical receives China patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - Taiwan Advance Bio-Pharmaceutical Inc :\n* Says it received China patent for method of producing recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo\n* Patent number is ZL 2014 1 0854099.1\nSource text in Chinese: goo.gl/DsGonZ\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-21T15:31:00.000+02:00",
    "crawled": "2018-02-22T17:52:59.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "taiwan",
        "advance",
        "inc",
        "say",
        "received",
        "china",
        "patent",
        "method",
        "producing",
        "recombinant",
        "protein",
        "use",
        "stimulant",
        "hematopoiesis",
        "vivo",
        "patent",
        "number",
        "zl",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}